Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs (ECLA'IR)
Organ Failure, Multiple
About this trial
This is an interventional prevention trial for Organ Failure, Multiple focused on measuring multidrug resistant bacteria, outbreak, prevention and infection control, bacterial typing, Fourier transform infrared spectroscopy
Eligibility Criteria
Inclusion Criteria: Adult patients hospitalized in ICU ESBL-E carrier Exclusion Criteria: none
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Standard care
Transmission of FTIR results
Standard care are defined by routine procedures implemented in each center to prevent and control the diffusion of MDR-E bacteria in ICUs. In the first period of the study, the frequency of cross transmission will be assessed by sequencing the first ESBL-E isolate in each carrier patients (first isolate of a given species)
In second phase of the study, the result of FTIR typing of recovered ESBL-E isolates will be weekly transmitted to participating centers.